|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
100 Binney St,Cambridge,Massachusetts,US
|
|
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes?Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease.With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
|
Foghorn Therapeutics, Inc Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Foghorn Therapeutics, Inc email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Foghorn Therapeutics, Inc customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.